Skip to main content

Month: March 2026

ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION

SARASOTA, Fla., March 11, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it is exploring discussions with third parties regarding the potential acquisition of additional assets in the central nervous system (CNS) space, with a specific focus on brain health and brain recovery indications that demonstrate strategic synergies with the Company’s lead candidate ONP-002 and its proprietary intranasal drug delivery platform. The Company’s portfolio expansion initiative is being pursued independently of its existing partnership with Receptor.AI, which focuses on artificial intelligence-enabled CNS drug discovery. Together, these two parallel strategies — traditional...

Continue reading

Gaia Announces March Investor Conference Schedule

BOULDER, Colo., March 11, 2026 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, will participate in the following upcoming investor events:Sidoti Small-Cap Virtual ConferenceDate: Wednesday, March 18th – Thursday, March 19th, 2026Location: Virtual38th Annual ROTH ConferenceDate: Sunday, March 22nd – Tuesday, March 24th, 2026Location: Dana Point, CaliforniaFor additional information about the events or to schedule a one-on-one meeting with Gaia, please contact GAIA@gateway-grp.com. About Gaia Gaia is a member-supported global video streaming service and community that produces and curates conscious media through four primary channels — Seeking Truth, Transformation, Alternative Healing, and Yoga — in four languages (English, Spanish, French, and German) to its members in 185 countries....

Continue reading

Navitas Adds Top-Side Cooled QDPAK and Low-Profile TO-247-4L to its Package Line-Up in the Latest 5th Generation GeneSiC™ Technology

QDPAK and Low-profile TO247 in the latest GeneSiC™ 5th Generation Trench-Assisted Planar SiC MOSFET technology deliver significant improvements in performance and lifetime for AI data centers, grid and energy infrastructure, and industrial electrification with voltage ratings of 1200 VNavitas Adds Top-Side Cooled QDPAK and Low-Profile TO-247-4L to its Package Line-Up in the Latest 5th Generation GeneSiC™ TechnologyQDPAK and Low-profile TO247 in the latest GeneSiC™ 5th Generation Trench-Assisted Planar SiC MOSFET technology deliver significant improvements in performance and lifetime for AI data centers, grid and energy infrastructure, and industrial electrification with voltageTORRANCE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), an industry leader in next-generation...

Continue reading

Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome

— Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant unmet medical need — — QRX003 lotion (4%) currently being evaluated in two late-stage whole-body clinical trials for treatment of Netherton Syndrome — — Fast Track Designation follows Pediatric Rare Disease and Orphan Drug Designation previously granted by the FDA and Orphan Drug Designation granted by the European Medicines Agency for QRX003 in Netherton Syndrome — ASHBURN, Va., March 11, 2026 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases, today announced that the U.S. Food...

Continue reading

Fluent, Inc. to Participate in the 38th Annual ROTH Conference

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading commerce media solutions provider, today announced that Don Patrick, Chief Executive Officer, and Ryan Perfit, Chief Financial Officer, will participate in the 38th Annual ROTH Conference on March 23-24 at the Ritz-Carlton Laguna Niguel in Dana Point, California. Management will be available for one-on-one meetings on Monday, March 23, and Tuesday, March 24. For more information or to register and schedule a one-on-one meeting, please contact your ROTH representative or visit https://ibn.fm/Roth2026Registration. About Fluent, Inc. Fluent, Inc. (NASDAQ: FLNT) is a commerce media solutions provider connecting top-tier brands with highly engaged consumers. Leveraging exclusive ad inventory, robust first-party data, privacy-first infrastructure, and proprietary...

Continue reading

AtlasClear Holdings to Attend the 38th Annual ROTH Conference

TAMPA, Fla., March 11, 2026 (GLOBE NEWSWIRE) — AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a financial services company building modern clearing, custody, and trading infrastructure, today announced that it will be participating in the 38th Annual ROTH Conference on March 22–24, 2026. Company executives will be available for one-on-one meetings with investors. Management will highlight the Company’s recent corporate developments and overarching strategy as AtlasClear continues building a technology-enabled financial infrastructure platform serving broker-dealers, fintech companies, and emerging financial institutions. To schedule a one-on-one meeting with AtlasClear management, please contact your ROTH representative. To learn more and submit a registration request, visit:https://ibn.fm/Roth2026Registration A...

Continue reading

K Wave Media Acquires KOSDAQ-Listed AI Company Hansol Inticube, Reporting $35M in Revenue for the First Nine Months of 2025

KWM Expands High-Tech Strategy with Second AI Technology Acquisition, Establishing Dedicated AI Division Alongside IP Content and Commercialization NEW YORK and SEOUL, South Korea, March 11, 2026 (GLOBE NEWSWIRE) — K Wave Media Ltd. (“KWM”), a global K-content and intellectual property company, today announced that, through its wholly owned subsidiary Play Company, KWM has completed the acquisition of a 42.5% controlling stake, including management rights, in KOSDAQ-listed Hansol Inticube Co., Ltd. (“Hansol Inticube”), an AI language and software development company. The entire purchase price for the transaction was paid in cash. The transaction officially closed on March 10, 2026, marking a major strategic step in KWM’s expansion into artificial intelligence and platform-based services as the company integrates Inticube’s AI capabilities...

Continue reading

HouseWorks Strengthens New England Presence Through Rhode Island Home Care Acquisition

BOSTON, March 11, 2026 (GLOBE NEWSWIRE) — HouseWorks Holdings, LLC (the “Company”), one of the nation’s leading personal care services companies, announced the acquisition of A Caring Experience, a Rhode Island-based home care provider. The acquisition expands HouseWorks’ footprint in New England and strengthens its ability to deliver high-quality in-home care to seniors across the region.   Founded in 1999, A Caring Experience, based in Cranston, Rhode Island, has a long-standing history of serving seniors throughout the state. In addition to home care services, the organization operates a caregiver training school, reinforcing its commitment to quality workforce development. “Dean and his team at A Caring Experience have built a strong reputation as a trusted in-home care provider for seniors throughout Rhode Island,” said Jon...

Continue reading

iHerb Achieves Record $2.9 Billion Net Sales in Fiscal 2025

Broad-Based Global Growth and Expanded Customer Trust Position eCommerce Retailer for Long-Term Scalable Success IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — iHerb, a leading global eCommerce retailer specializing in vitamins, minerals, supplements and other health and wellness products, today announced record financial and operational performance for fiscal year 2025, highlighted by generating $2.9 billion in net sales, up 19% year-over-year while significantly increasing profitability. Sales increased in 28 of iHerb’s top 30 countries, with growth across all regions and product categories, reflecting resilient global demand and continued market share gains. The company fulfilled more than 44 million orders during the year and served 15 million active customers worldwide. More customers are increasingly choosing iHerb as their...

Continue reading

Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

– YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40%, when compared to 2024 – – Company earned $35.6 million in total revenue in 2025, up from $7.6 million in the prior year – – YCANTH dispensed applicator units grew 99% to 51,296 in 2025 versus 25,773 units in 2024 – Company is advancing VP-315, its novel oncolytic peptide, toward a Phase 3 program for basal cell carcinoma in 2026, further analysis supports abscopal effects and tumor size reduction in untreated lesions – – First patient dosed in the first Phase 3 study of YCANTH for the treatment of common warts in December 2025, and Company expects to initiate the second Phase 3 study in the US and Japan with Torii Pharmaceutical in mid-2026 – – Company gained alignment with the European Medicines Agency supporting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.